Skip to search formSkip to main contentSkip to account menu

LY686017

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

PyridinesTriazoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
Development of the 2nd generation neurokinin-1 receptor antagonist LY686017 for social anxiety disorder
2008
2008
PKPD Modeling of Brain Receptor Occupancy from Animal to Man for Establishing the Clinical Dose of the NK-1 Antagonist LY686017
: RO simulations with the human PKRO model confirmed the dose of 50 mg QD for POC studies: RO predictions were > 90% as a mean… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)